These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 36681041)
21. Does melatonin mediate the therapeutic effects of 5-HT reuptake inhibitors in obsessive compulsive disorder? Sandyk R Int J Neurosci; 1992; 64(1-4):221-3. PubMed ID: 1342043 [No Abstract] [Full Text] [Related]
30. Efficacy of clomipramine in obsessive-compulsive disorder. Howland RH Anxiety; 1996; 2(1):56-7. PubMed ID: 9160602 [No Abstract] [Full Text] [Related]
31. Obsessive-compulsive disorder due to neuroacanthocytosis treated with citalopram. A case report. Habermeyer B; Fuhr P; Hiss B; Alber C; Müller-Spahn F Pharmacopsychiatry; 2006 Sep; 39(5):193-4. PubMed ID: 16944412 [TBL] [Abstract][Full Text] [Related]
32. Obsessive-compulsive spectrum disorders: effective treatment with paroxetine. Ravindran AV; Lapierre YD; Anisman H Can J Psychiatry; 1999 Oct; 44(8):805-7. PubMed ID: 10566112 [TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for clinicians. Zai G; Brandl EJ; Müller DJ; Richter MA; Kennedy JL Pharmacogenomics; 2014 Jun; 15(8):1147-57. PubMed ID: 25084207 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness of fluoxetine on various subtypes of obsessive-compulsive disorder. Farnam A; Goreishizadeh MA; Farhang S Arch Iran Med; 2008 Sep; 11(5):522-5. PubMed ID: 18759519 [TBL] [Abstract][Full Text] [Related]
35. Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder. Humble M; Bejerot S; Bergqvist PB; Bengtsson F Biol Psychiatry; 2001 Feb; 49(4):360-8. PubMed ID: 11239907 [TBL] [Abstract][Full Text] [Related]